Trials / Recruiting
RecruitingNCT07364032
Comparison Between a Mindfulness-Based Program and Standard Therapeutic Follow-Up During Pregnancy
A Randomized Controlled Trial Comparing a Mindfulness-based Program With Standard Therapeutic Follow-up During Pregnancy: Effects on Maternal Well-being, Infant Outcomes, and Mother-Infant Attachment
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Universite Cote d'Azur · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study aims to evaluate the effects of a 6-week mindfulness meditation program in pregnant women, compared with a psychological support control program. Participants in the mindfulness arm will complete one instructor-led meditation session per week and five guided audio meditation sessions at home each week. The primary objectives are to determine whether the mindfulness program leads to: Reduced negative affect, including stress, anxiety, depression, and sleep disturbances during pregnancy. Increased positive affect, such as mindfulness skills, self-efficacy, happiness, and life satisfaction. Enhanced maternal-fetal attachment during pregnancy and improved maternal-infant attachment one month postpartum. Improved mother-infant interaction quality at 3 months postpartum. More secure infant attachment at 12 months. Better infant outcomes, including reduced crying intensity/duration at 1 and 3 months, and improved sleep quality at 12 months. Overall, the study evaluates whether the mindfulness program provides greater benefits than a standard parenting support intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Mindfulness program | 6 weeks of mindfulness |
| OTHER | Consultations | 6 week of consultation with 1 consultation per week |
Timeline
- Start date
- 2023-03-31
- Primary completion
- 2026-08-30
- Completion
- 2026-10-31
- First posted
- 2026-01-23
- Last updated
- 2026-01-23
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT07364032. Inclusion in this directory is not an endorsement.